The emergence of resistance is a preoccupant health threat and the development of new strategies and the use of novel compounds are in demand. Specifically, biofilm infections are a serious threat, causing chronic, nosocomial and biomaterial related infections, being related to dissemination of antibiotic resistance. Pseudomonas aeruginosa and Staphylococcus aureus are great developers of resistance and their ability to form biofilms makes them responsible for severe chronic infections. In this work, we associated the use of novel compounds antimicrobial peptides (AMPs) with a combination strategy. The AMP/antibiotic colistin was combined with three other AMPs (linear tachyplesin I; temporin A; citropin 1.1). Previous results showed the...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Today, we are facing a major challenge regarding the development of new strategies and the discovery...
[Excerpt] Introduction The solution to clinically relevant biofilms and antimicrobial resistance may...
Antimicrobial research is being pressured to look for more effective therapeutics for the ever-growi...
Today, we are facing a major challenge regarding the development of new strategies and the discovery...
Antimicrobial research is increasingly being focused on the problem of microbial resistance and biof...
Aim:To test ocellatin peptides (ocellatins-PT2-PT6) for antibacterial and antibiofilm activities and...
The great clinical significance of biofilm-associated infections and their inherent recalcitrance to...
The great clinical significance of biofilm-associated infections and their inherent recalcitrance to...
Staphylococcus aureus is a human pathogen known to be resistant to antibiotics since the mid-20th ce...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Today, we are facing a major challenge regarding the development of new strategies and the discovery...
[Excerpt] Introduction The solution to clinically relevant biofilms and antimicrobial resistance may...
Antimicrobial research is being pressured to look for more effective therapeutics for the ever-growi...
Today, we are facing a major challenge regarding the development of new strategies and the discovery...
Antimicrobial research is increasingly being focused on the problem of microbial resistance and biof...
Aim:To test ocellatin peptides (ocellatins-PT2-PT6) for antibacterial and antibiofilm activities and...
The great clinical significance of biofilm-associated infections and their inherent recalcitrance to...
The great clinical significance of biofilm-associated infections and their inherent recalcitrance to...
Staphylococcus aureus is a human pathogen known to be resistant to antibiotics since the mid-20th ce...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...
Staphylococcus aureus can develop resistance by mutation, transfection or biofilm formation. Resista...